Skip to Main Content

Paper Details

Reduction in Revascularization With Icosapent Ethyl: Insights From REDUCE-IT Revascularization Analyses.
Circulation
37
2021
Icosapent Ethyl, Icosapent ethyl, Patients, REDUCE, cardiovascular disease, diabetes, icosapent ethyl, low-density lipoprotein, patient, patients, statin, triglycerides
Author NameAffiliation
Deepak L BhattBrigham and Women's Hospital Heart and Vascular Center, Harvard Medical School
Duane S PintoBaim Clinical Research Institute
Robert P GiuglianoBrigham and Women's Hospital Heart and Vascular Center, Harvard Medical School
Matthew J BudoffDavid Geffen School of Medicine, Lundquist Institute
Jean-Claude TardifMontreal Heart Institute, Universite de Montreal
Christie M BallantyneBaylor College of Medicine, and Center for Cardiovascular Disease Prevention
Christie M BallantyneBaylor College of Medicine, and Center for Cardiovascular Disease Prevention
  • 1 - 7

Datasets

Release 1.2